Emily Dressler to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Emily Dressler has written about Clinical Trials, Phase II as Topic.
Connection Strength
1.951
-
Yan D, Tait C, Wages NA, Kindwall-Keller T, Dressler EV. Generalization of the time-to-event continual reassessment method to bivariate outcomes. J Biopharm Stat. 2019; 29(4):635-647.
Score: 0.679
-
Yan D, Wages NA, Dressler EV. Improved adaptive randomization strategies for a seamless Phase I/II dose-finding design. J Biopharm Stat. 2019; 29(2):333-347.
Score: 0.650
-
Liu M, Dressler EV. A predictive probability interim design for phase II clinical trials with continuous endpoints. Stat Med. 2018 05 30; 37(12):1960-1972.
Score: 0.622